TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SPRO

Spero Therapeutics Inc

Healthcare · Biotechnology

1.20$ -2.5% vs. previous close Closing price · As of: Oct 5, 2026

Statements

Balance Sheet

Spero Therapeutics Inc (SPRO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 53 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SPRO
Line item Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
– 14 40 40 32 32 81 73 136 129 125 122 113 106 110 98 157 153 143 120 145 171 146 64 64 125 113 99 107 182 168 150 135 111 78 62 54 69 59 53
– 12 37 37 27 27 80 70 134 115 116 113 104 95 98 85 143 139 129 106 132 158 133 52 53 109 102 88 102 131 140 122 132 107 75 59 52 67 58 52
– 10 36 36 25 25 53 49 40 34 49 71 46 30 64 65 125 85 77 72 113 113 72 45 50 109 96 78 94 76 82 64 76 53 49 31 49 40 56 51
– 10 – 36 25 87 75 67 131 115 106 103 94 82 89 71 127 127 116 99 123 146 122 45 50 109 96 78 94 76 82 64 76 53 49 31 49 40 56 51
– 0.3 0.2 0.1 0.5 0.5 3.1 2.6 1.3 1.3 1.4 3.0 6.4 10 5.3 2.0 10 6.2 8.6 2.2 2.6 2.6 2.0 1.6 1.0 1.1 1.9 2.1 3.0 51 54 51 53 52 24 24 2.5 25 0.0 0.0
– – – – 0.0 0.0 -4.8 0.0 0.0 -8.8 – – – -13 – – – -12 – – – – – – – -4.5 – – – 0.0 0.0 – – – – – – – – –
– 1.5 1.3 1.3 1.3 1.2 1.1 1.0 2.2 2.9 7.2 6.9 6.5 7.1 6.9 6.8 1.8 1.7 1.5 1.4 7.7 7.6 7.2 6.2 5.9 5.5 0.3 4.8 – – – – – – – – – – – –
– – – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– – – – 0.0 0.0 0.0 0.0 0.0 – – – – – – – – – – – – – – – – – – – – – – – – – – – – – – –
– 7.4 6.8 6.8 7.3 7.3 6.2 6.9 11 13 11 13 19 32 27 24 24 21 25 29 33 83 83 28 32 49 48 44 53 75 71 69 70 64 44 29 28 9.9 6.1 8.6
– 6.9 6.4 6.4 6.9 6.9 5.8 6.6 10 12 6.6 8.2 15 27 23 19 18 14 18 13 17 19 69 14 16 22 23 17 25 37 42 46 49 49 29 15 14 8.9 5.5 8.4
– – – – 0.2 0.2 0.2 0.2 0.2 0.2 0.6 0.6 0.4 0.9 0.9 0.9 1.5 0.9 1.0 1.0 1.0 1.4 52 1.5 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.7 1.8 1.8 1.9 2.0 2.0 2.0
– 1.1 1.4 1.4 2.0 7.8 1.0 0.7 1.4 3.6 0.6 1.0 2.5 4.1 9.0 1.6 2.5 1.2 3.8 1.6 3.2 1.1 4.8 1.7 2.6 0.6 0.6 1.3 1.1 1.4 3.1 2.7 6.1 7.3 1.8 0.8 1.4 0.7 0.2 0.2
– – – – 0.0 0.0 0.0 0.0 0.0 – 4.4 0.3 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 0.1 – – – 0.1 – 0.1 – – – – – – – – – – – – –
– 10 -38 32 24 85 75 65 125 116 113 109 93 75 82 74 133 132 119 90 112 88 62 36 32 76 65 55 54 107 96 81 66 46 34 33 26 59 53 44
– -45 -72 -72 -82 -82 -107 -117 -128 -139 -144 -157 -174 -199 -223 -240 -259 -278 -297 -316 -338 -367 -400 -429 -441 -414 -427 -439 -442 -391 -404 -422 -439 -460 -474 -475 -483 -451 -458 -468
6.6 6.6 6.6 6.6 13 13 14 14 17 18 17 18 19 19 20 21 22 27 29 30 32 32 33 33 36 49 53 53 53 53 54 54 54 54 55 56 56 59 57 58

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?